Nigeria is motivated by the suspension of vaccine deliveries from India, which will prevent it from receiving millions of doses of anti-covid-19 vaccine. The African giant has announced that it is making progress in the development of its own vaccine. The country released $ 25 million earlier this year to develop a vaccine response. Two vaccine candidates are currently being developed according to the boss of the Task Force dedicated to the development of the vaccine, Boss Mustapha. "  Nigerian scientists have produced at least two local covid-19 vaccines which are awaiting clinical trials and certification ... This is a development that will open a new perspective in scientific breakthroughs, and strengthen the morale and image ", did he declare.
Nigeria has joined forces with the University of the Nile for national production, according to the Vanguard daily. Three federal agencies are said to be involved in research, with the aim of producing a vaccine against the coronavirus. This willingness of Nigeria to produce its own vaccine would limit some delays in the Covax Initiative, intended to provide vaccines to developing countries. To this must be added the stopping of India to export, favoring its population. Abuja has real industrial capacities to embark on large-scale production and supply the sub-region. While Nigeria aims to vaccinate 140 of its 200 million inhabitants, it has so far received only 4 of the 16 million doses required. " I ask all the agencies concerned to provide the necessary support and an environment conducive to the smooth running of the remaining protocols for the certification of these vaccines, in order to encourage and motivate other researchers,  ”said Boss Mustapha.
Nigeria is not the only country to embark on the development of anti-covid-19 vaccines on African soil. The current president of the African Union (AU) and head of state of DR Congo, Félix Tshisekedi, recently launched work on anti-covid-19 vaccination in Africa and the possibility of producing on the continent. Officials from the World Health Organization, the World Trade Organization and NEPAD have supported the initiative. To date, Africa has an estimated 4.4 million cases and 115,000 deaths from the coronavirus. But she only received 2% of the vaccine doses allocated to her.